Fabino Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve the unaudited Stadalone Finacial Result along with Limited Review Report for the Half yearly ended September 2026.

The Manager Listing Department, BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400001. Scrip Code: 543444 Subject: Prior intimation under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations') Dear Sir/Madam, The prior intimation is hereby given pursuant to Regulation 29(1)(a) of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 that a meeting of the Board of Directors of the Fabino Enterprises Limited is scheduled to be held on Wednesday, November 11,2026 inter alia to consider and approve following business at the meeting: 1. To Consider and approve the Unaudited Standalone Financial Results for the half year ended September 30,2026 along with Limited Review Report thereon. 2. To deliberate and undertake any other business matters deemed necessary for general corporate purposes, with the permission of the Chairperson. In pursuance of our earlier intimation dated September 25, 2026, and in accordance with the provisions of the Company’s Code of Conduct for Prevention of Insider Trading, the trading window shall re-open 48 hours after the declaration of the aforesaid Financial Results to the Stock Exchanges. This intimation is also being made available on the website of the Company at www.fabinolife.com Kindly take the above intimation on your record. Thanks & Regards, For Fabino Enterprises Limited (Formerly known as Fabino Life Sciences Limited) Aditya Mahavir Jain Managing Director DIN: 09353344 Date: 05.11.2026 Place: Sonipat, Haryana